Dementia with Diabetes - Pipeline Insight, 2020

Publisher Name :
Date: 24-Sep-2020
No. of pages: 75
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Dementia with Diabetes - Pipeline Insight, 2020," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Dementia with Diabetes pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Geography Covered

- Global coverage

Dementia with Diabetes Understanding

Dementia with Diabetes: Overview

Diabetes can cause several complications, such as damage to blood vessels. Diabetes is considered a risk factor for vascular dementia. This type of dementia occurs due to brain damage that is often caused by reduced or blocked blood flow to brain. Many people with diabetes have brain changes that are hallmarks of both Alzheimer's disease and vascular dementia. Some researchers think that each condition fuels the damage caused by the other.

There's a lot of research suggesting a connection between diabetes and Alzheimer's-though those connections aren't yet fully understood. Not all studies confirm the connection, but many do suggest that people with diabetes, especially type 2 diabetes, are at higher risk of eventually developing Alzheimer's dementia or other dementias. Diabetes may also increase the risk of developing mild cognitive impairment (MCI), a condition in which people experience more thinking (cognitive) and memory problems than are usually present in normal aging.

Insulin in the Brain

Sensitivity of target cells in the periphery and in the central nervous system (CNS) to insulin, a peptide hormone secreted by pancreatic ß-cells, is suppressed in type 2 diabetes. The CNS is rich with insulin receptors, most prominently in areas important for learning and memory, including the hippocampus, amygdala, parahippocampal gyrus, thalamus, and caudate-putamen.

Role of Insulin in Learning and Memory

A number of studies support insulin as an important factor in normal memory functioning. Potential mechanisms for the influence of insulin on memory include regional effects of insulin on cerebral glucose metabolism, influence on components of the long-term potentiation cascade, and modulation of acetylcholine and norepinephrine, neurotransmitters that are known to influence cognitive function.

Treatment

Currently, there are different classes of orally available pharmacological agents to treat Type II diabetes: 1) sulfonylureas, 2) meglitinides, 3) metformin (a biguanide), 4) thiazolidinediones (TZDs), 5) alpha glucosidase inhibitors, 6) dipeptidyl peptidase IV (DPP-4) inhibitors, 7) bile acid sequestrants, 8) dopamine agonists, and 9) sodium-glucose transport protein 2 (SGLT2) inhibitors. The treatment regimen for Dementia with Diabetes includes non-insulin therapy (Metformin, Thiazolidinedione, Sulfonylureas Meglitinides, Dipeptidyl peptidase-4 inhibitors and Sodium-glucose cotransporter-2 (SGLT-2)), and insulin therapy.

Dementia with Diabetes Emerging Drugs Chapters

This segment of the Dementia with Diabetes report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.

Dementia with Diabetes Emerging Drugs

- Azeliragon (TTP488): vTv Therapeutics

Azeliragon (TTP488) is developed by vTv Therapeutics which is currently in phase II/III clinical developmental trial in patients with mild- Alzheimer's disease in patients with type 2 diabetes. Azeliragon (TTP488) is an orally bioavailable small molecule that inhibits the receptor for advanced glycation endproduct (RAGE) being developed for dementia. RAGE is an immunoglobulin-like cell surface receptor that is overexpressed in brain tissues of patients with Alzheimer's disease. vTv Therapeutics has also received fast-track designation from the US FDA for Azeliragon in Alzheimer's disease.

Further product details are provided in the report……..

Dementia with Diabetes: Therapeutic Assessment

This segment of the report provides insights about the different Dementia with Diabetes drugs segregated based on following parameters that define the scope of the report, such as:

- Major Players in Dementia with Diabetes

There are approx. 5+ key companies which are developing the therapies for Dementia with Diabetes. The companies which have their Dementia with Diabetes drug candidates in the advanced stage, i.e. phase III and include, vTv Therapeutics etc.

Phases

DelveInsight's report covers around 5+ products under different phases of clinical development like

- Mid-stage products (Phase II and Phase I/II)

- Early-stage products (Phase I/II and Phase I) along with the details of

- Pre-clinical and Discovery stage candidates

- Discontinued & Inactive candidates

- Route of Administration

Dementia with Diabetes pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

- Subcutaneous

- Intravenous

- Oral

- Intramuscular

- Molecule Type

Products have been categorized under various Molecule types such as

- Proteins and Peptides

- Small molecules

- Hormones

- Enzymes

- Product Type

Drugs have been categorized under various product types like Mono, Combination and Mono/Combination.

Dementia with Diabetes: Pipeline Development Activities

The report provides insights into different therapeutic candidates in phase II, I, preclinical and discovery stage. It also analyses Dementia with Diabetes therapeutic drugs key players involved in developing key drugs.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing along with a thorough therapeutic assessment of emerging Dementia with Diabetes drugs.

Report Highlights

- The companies and academics are working to assess challenges and seek opportunities that could influence Dementia with Diabetes R&D. The therapies under development are focused on novel approaches to treat/improve Dementia with Diabetes.

- Currently, several trials with anti-diabetic drugs in AD are underway and their results are expected in the next few years. Besides, further studies exploring the molecular mechanisms underlying the favorable effects of anti-diabetic drugs in the CNS could open new perspectives on future treatments.

Dementia with Diabetes Report Insights

- Dementia with Diabetes Pipeline Analysis

- Therapeutic Assessment

- Unmet Needs

- Impact of Drugs

Dementia with Diabetes Report Assessment

- Pipeline Product Profiles

- Therapeutic Assessment

- Pipeline Assessment

- Inactive drugs assessment

- Unmet Needs

Key Questions

Current Treatment Scenario and Emerging Therapies:

- How many companies are developing Dementia with Diabetes drugs?

- How many Dementia with Diabetes drugs are developed by each company?

- How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Dementia with Diabetes?

- What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Dementia with Diabetes therapeutics?

- What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?

- What are the clinical studies going on for Dementia with Diabetes and their status?

- What are the key designations that have been granted to the emerging drugs?

Key Players

- vTv Therapeutics

Key Products

- Azeliragon (TTP488)

Dementia with Diabetes - Pipeline Insight, 2020

Table of Contents

Introduction
Executive Summary
Dementia with Diabetes: Overview
* Causes
* Mechanism of Action
* Signs and Symptoms
* Diagnosis
* Disease Management
Pipeline Therapeutics
* Comparative Analysis
Therapeutic Assessment
* Assessment by Product Type
* Assessment by Stage and Product Type
* Assessment by Route of Administration
* Assessment by Stage and Route of Administration
* Assessment by Molecule Type
* Assessment by Stage and Molecule Type
Dementia with Diabetes - DelveInsight's Analytical Perspective
In-depth Commercial Assessment
* Dementia with Diabetes companies' collaborations, Licensing, Acquisition -Deal Value Trends
Dementia with Diabetes Collaboration Deals
* Company-Company Collaborations (Licensing / Partnering) Analysis
* Company-University Collaborations (Licensing / Partnering) Analysis
Mid Stage Products (Phase II/III)
* Comparative Analysis
Azeliragon (TTP488): vTv Therapeutics
* Product Description
* Research and Development
* Product Development Activities
Drug profiles in the detailed report…..
Pre-clinical and Discovery Stage Products
* Comparative Analysis
* Product Description
* Research and Development
* Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
* Comparative Analysis
Dementia with Diabetes Key Companies
Dementia with Diabetes Key Products
Dementia with Diabetes- Unmet Needs
Dementia with Diabetes- Market Drivers and Barriers
Dementia with Diabetes- Future Perspectives and Conclusion
Dementia with Diabetes Analyst Views
Dementia with Diabetes Key Companies
Appendix

List of Tables

Table 1 Total Products for Dementia with Diabetes
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products

List of Figures

Figure 1 Total Products for Dementia with Diabetes
Figure 2 Late Stage Products
Figure 3 Mid Stage Products
Figure 4 Early Stage Products
Figure 5 Preclinical and Discovery Stage Products
Figure 6 Assessment by Product Type
Figure 7 Assessment by Stage and Product Type
Figure 8 Assessment by Route of Administration
Figure 9 Assessment by Stage and Route of Administration
Figure 10 Assessment by Molecule Type
Figure 11 Assessment by Stage and Molecule Type
Figure 12 Inactive Products
  • Global Specialty Pharmaceutical Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 103
    The Specialty Pharmaceutical market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Specialty Pharmaceutical market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Specialty Pharmaceutical market. The report focuses on well-known providers in the global Specialty Pharmaceutical industry, market segmen......
  • Global Pharma Pellets Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 114
    The Pharma Pellets market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Pharma Pellets market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Pharma Pellets market. The report focuses on well-known providers in the global Pharma Pellets industry, market segments, competition, and the macro environme......
  • Global Transdermal Patch Drug Delivery System Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 107
    The Transdermal Patch Drug Delivery System market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Transdermal Patch Drug Delivery System market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Transdermal Patch Drug Delivery System market. The report focuses on well-known providers in the global Transd......
  • Global Calcium Dobesilate Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 124
    The Calcium Dobesilate market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Calcium Dobesilate market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Calcium Dobesilate market. The report focuses on well-known providers in the global Calcium Dobesilate industry, market segments, competition, and the......
  • Global Aliskiren Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 120
    The Aliskiren market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Aliskiren market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Aliskiren market. The report focuses on well-known providers in the global Aliskiren industry, market segments, competition, and the macro environment. U......
  • Global Plasminogen Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 103
    The Plasminogen market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Plasminogen market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Plasminogen market. The report focuses on well-known providers in the global Plasminogen industry, market segments, competition, and the macro environment. ......
  • Global Active Pharmaceutical Ingredients Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 111
    The Active Pharmaceutical Ingredients market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Active Pharmaceutical Ingredients market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Active Pharmaceutical Ingredients market. The report focuses on well-known providers in the global Active Pharmaceutical......
  • Global Acne Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 117
    The Acne market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Acne market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Acne market. The report focuses on well-known providers in the global Acne industry, market segments, competition, and the macro environment. Under COVID-19 Outbre......
  • Global Oncology Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 112
    The Oncology market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Oncology market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Oncology market. The report focuses on well-known providers in the global Oncology industry, market segments, competition, and the macro environment. Under......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs